• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,315.04 77.05
( 0.10%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
60,874.73 -534.56
(-0.87%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

RPG Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532983
INE105J01010
366.0261581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RPGLIFE
33.82
3796.78
EPS(TTM)
Face Value()
Div & Yield %
67.87
8
1.05
 

genpharmasec limited
Lloyds Enterprises consolidated net profit rises 304.14% in the March 2026 quarter
May 08,2026
Net profit of Lloyds Enterprises rose 304.14% to Rs 38.11 crore in the quarter ended March 2026 as against Rs 9.43 crore during the previous quarter ended March 2025. Sales rose 47.07% to Rs 719.64 crore in the quarter ended March 2026 as against Rs 489.32 crore during the previous quarter ended March 2025.

For the full year,net profit rose 396.39% to Rs 283.44 crore in the year ended March 2026 as against Rs 57.10 crore during the previous year ended March 2025. Sales rose 18.01% to Rs 1756.29 crore in the year ended March 2026 as against Rs 1488.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales719.64489.32 47 1756.291488.29 18
OPM %6.295.07 -6.607.93 -
PBDT98.6945.11 119 495.44173.83 185
PBT91.6641.86 119 472.61163.15 190
NP38.119.43 304 283.4457.10 396